Cargando…

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma

Chemoresistance, especially temozolomide (TMZ) resistance, is a major clinical challenge in the treatment of glioblastoma (GBM). Exploring the mechanisms of TMZ resistance could help us identify effective therapies. Adenosine deaminases acting on RNA (ADARs) are very important in RNA modification th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Can, Chen, Xi, Yan, Yuanliang, Ren, Xinxin, Wang, Xiang, Peng, Bi, Cai, Yuan, Liang, Qiuju, Xu, Zhijie, Peng, Jinwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844449/ https://www.ncbi.nlm.nih.gov/pubmed/35177985 http://dx.doi.org/10.3389/fphar.2022.768743

Ejemplares similares

Downregulated ADARB1 Facilitates Cell Proliferation, Invasion and has Effect on the Immune Regulation in Ovarian Cancer
por: Zhu, Wei, et al.
Publicado: (2021)

Role of downregulated ADARB1 in lung squamous cell carcinoma
por: Wang, Xiang, et al.
Publicado: (2020)

Function of low ADARB1 expression in lung adenocarcinoma
por: Wang, Xiang, et al.
Publicado: (2019)

Drug metabolism-related gene ABCA1 augments temozolomide chemoresistance and immune infiltration abundance of M2 macrophages in glioma
por: Yan, Yuanliang, et al.
Publicado: (2023)

Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma
por: Zhou, Shuyi, et al.
Publicado: (2022)

Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis
por: Yi, Qiaoli, et al.
Publicado: (2022)

Case-control study of ADARB1 and ADARB2 gene variants in migraine
por: Gasparini, Claudia F, et al.
Publicado: (2015)

Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer
por: Cai, Yuan, et al.
Publicado: (2021)

The novel roles of virus infection-associated gene CDKN1A in chemoresistance and immune infiltration of glioblastoma
por: Hu, Kuan, et al.
Publicado: (2021)

Aberrant expression of KDM1A inhibits ferroptosis of lung cancer cells through up-regulating c-Myc
por: Lu, Can, et al.
Publicado: (2022)

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
por: Sun, Stella, et al.
Publicado: (2012)

Downregulated ferroptosis‐related gene SQLE facilitates temozolomide chemoresistance, and invasion and affects immune regulation in glioblastoma
por: Yao, Lei, et al.
Publicado: (2022)

Aberrant Transcriptional Regulation of Super-enhancers by RET Finger Protein-histone Deacetylase 1 Complex in Glioblastoma: Chemoresistance to Temozolomide
por: NATSUME, Atsushi, et al.
Publicado: (2019)

Non-coding RNAs: The recently accentuated molecules in the regulation of cell autophagy for ovarian cancer pathogenesis and therapeutic response
por: Peng, Bi, et al.
Publicado: (2023)

SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis
por: Dai, Shuang, et al.
Publicado: (2018)

Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis
por: Dai, Shuang, et al.
Publicado: (2019)

Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases
por: Proto, Maria Chiara, et al.
Publicado: (2022)

Integrative bioinformatics and experimental analysis revealed TEAD as novel prognostic target for hepatocellular carcinoma and its roles in ferroptosis regulation
por: Ren, Xinxin, et al.
Publicado: (2022)

Unraveling the significance of exosomal circRNAs in cancer therapeutic resistance
por: Kang, Fanhua, et al.
Publicado: (2023)

Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells
por: Cheng, Quan, et al.
Publicado: (2017)

The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinoma
por: Peng, Bi, et al.
Publicado: (2021)

Identification of m6A-Associated Gene DST as a Prognostic and Immune-Associated Biomarker in Breast Cancer Patients
por: Qiu, Xiangyuan, et al.
Publicado: (2022)

Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma
por: Song, Liying, et al.
Publicado: (2022)

Polydopamine-based loaded temozolomide nanoparticles conjugated by peptide-1 for glioblastoma chemotherapy and photothermal therapy
por: Wu, Hao, et al.
Publicado: (2023)

MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype
por: Yan, Wei, et al.
Publicado: (2015)

Hypoxanthine phosphoribosyl transferase 1 metabolizes temozolomide to activate AMPK for driving chemoresistance of glioblastomas
por: Yin, Jianxing, et al.
Publicado: (2023)

Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration
por: Wang, Siqi, et al.
Publicado: (2022)

Current Understanding of Exosomal MicroRNAs in Glioma Immune Regulation and Therapeutic Responses
por: Peng, Jinwu, et al.
Publicado: (2022)

Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma
por: Ren, Xinxin, et al.
Publicado: (2021)

Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
por: Wang, Ke, et al.
Publicado: (2017)

Mitochondrial Peptide Humanin Facilitates Chemoresistance in Glioblastoma Cells
por: Peña Agudelo, Jorge A., et al.
Publicado: (2023)

Integrative bioinformatics and experimental analysis revealed down-regulated CDC42EP3 as a novel prognostic target for ovarian cancer and its roles in immune infiltration
por: Yan, Yuanliang, et al.
Publicado: (2021)

The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Zeng, Jiajia, et al.
Publicado: (2023)

The implication of pyroptosis in cancer immunology: Current advances and prospects
por: Liu, Wei, et al.
Publicado: (2022)

Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma
por: Zhang, Zhuoran, et al.
Publicado: (2019)

Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D
por: Munoz, Jessian L., et al.
Publicado: (2019)

Targeting autophagy to sensitive glioma to temozolomide treatment
por: Yan, Yuanliang, et al.
Publicado: (2016)

Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications
por: Zhou, Zhiyang, et al.
Publicado: (2021)

Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC
por: Zheng, Hongmei, et al.
Publicado: (2021)

Cost-Effectiveness of Short-Course Radiation Plus Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Among Elderly Patients in China and the United States
por: Chen, Jigang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1r913aj6l8qa4p9sekj270t76k